 Boston Scientific Corporation NYSE: BSX generated net sales of 2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of 2.97 billion. Sales increased 10.3 YY on a reported basis and 10.6 on an organic basis, lower than the Companys guidance of 12 - 14. 